Received 12 February 2001/Returned for modification 8 April
2001/Accepted 13 May 2001
 |
TEXT |
Lyme disease, a disorder which may
affect multiple organ systems, results from infection with the
spirochete Borrelia burgdorferi. Between 1989 and 1997, 114,314 cases of Lyme disease were reported to the Centers for Disease
Control and Prevention, making Lyme disease the most common
vector-borne disease in the United States (16, 21). Early
Lyme disease is manifested by a characteristic skin rash, erythema
migrans (EM), and is frequently accompanied by systemic symptoms
(14, 15). Molecular analysis of B. burgdorferi isolates has resulted in the differentiation of B. burgdorferi sensu lato into 10 distinct species (23).
B. burgdorferi sensu stricto is the only known Lyme disease
borrelia infecting patients in North America. Significant genetic
heterogeneity among B. burgdorferi sensu stricto isolates in
North America has been reported (1, 6, 8, 13). The type
strain of B. burgdorferi sensu stricto, B31 has a large
linear genome of 910,725 bp and 21 linear and circular plasmids with a
total size of 610,694 bp (3, 7).
It has long been recognized that the clinical expression of B. burgdorferi infection is diverse (15). Possible
explanations for this variability are differences in the genotypes of
the infecting strain of B. burgdorferi. We developed a
typing method based on restriction fragment length polymorphism (RFLP)
in the 16S-23S ribosomal DNA (rDNA) spacer of B. burgdorferi
and used it to analyze clinical isolates obtained from early Lyme
disease patients (9). A highly significant association was
found between the infecting RFLP type in the skin and the presence of
spirochetemia or multiple EM lesions (25), suggesting that
differences in the clinical presentations of Lyme disease patients may,
indeed, be related to B. burgdorferi genotype. rDNA spacer
analysis provides genetic typing information for a single genomic locus
and interrogates a chromosomal region which is unlikely to have a
direct role in pathogenesis. In order to obtain additional, broader
typing information, 48 cutaneous isolates from early Lyme disease
patients were analyzed by pulsed-field gel electrophoresis (PFGE).
Subjects, skin biopsy, and cultivation.
All subjects were
adults with EM enrolled in a prospective study at the Lyme Disease
Diagnostic Center of the Westchester Medical Center, Valhalla, N.Y.
Skin biopsy specimens (2 mm) were obtained from the leading edge of
primary EM lesions and cultured in BSK-II medium as described
previously (19).
PFGE.
Spirochetes were harvested by centrifugation and washed
twice with sterile phosphate-buffered saline. The cells were
resuspended in 50 mM Tris-HCl-150 mM NaCl (pH 8.0), and an equal
volume of 1.8% low-gelling-temperature agarose (SeaPlaque; FMC Corp.,
Rockland, Maine) was added. The cells, in agarose blocks, were lysed as described previously (5). For plasmid analysis, blocks
were washed extensively with 10 mM Tris-HCl-1 mM EDTA (pH 8.0) and PFGE was performed in 0.5× Tris-borate-EDTA at 14°C on a Bio-Rad CHEF DR II electrophoresis system. One percent agarose gels were run at
a constant voltage (6 V/cm) for 19 h, with a switch time of 0.7 to
2.2 s. For chromosome restriction fragment analysis, agarose
blocks containing B. burgdorferi were incubated overnight at
37°C with 40 to 50 U of MluI in 0.5 ml of 50 mM Tris-HCl
(pH 7.5)-10 mM MgCl2-100 mM NaCl-1 mM dithioerythritol.
PFGE was performed as described above, except that a switch time of 6 to 25 s was used.
The relative proportions of the three rDNA spacer RFLP types (RSTs)
among the 48 isolates (29.2, 41.7, and 29.2% for RST1, RST2, and RST3,
respectively) were similar to those for the larger group of cutaneous
isolates reported previously (25.1, 38.3, and 30.1% for RST1, RST2,
and RST3, respectively) (10). Total genomic DNA was
digested with MluI, and the resultant fragments were
resolved by PFGE. The results, summarized schematically in Fig.
1, revealed six distinct pulsed-field gel
(PFG) patterns. Fifty-two percent (25 of 48) displayed a pattern
designated type A. An additional 16.7% (8 of 48) had the pattern
designated type B, and 12.5% (6 of 48) showed a type D pattern; the
remaining isolates were equally distributed between types C, E, and F. These patterns were all observed in a previous study of representative
B. burgdorferi isolates by Mathiesen et al.
(13) and are designated here types A to F, after their
nomenclature. Of the 65 human isolates characterized in the earlier
study, 54 (83%) were PFG type A, which was also the predominant PFG
type (52%) among the isolates in the present investigation.
Interestingly, PFG type E was observed only in ticks by Mathiesen et
al. (13), whereas three PFG type E isolates were detected
among the human isolates in the present analysis. Thus, all major North
American B. burgdorferi sensu stricto PFG types are found in
a narrowly defined geographic location (Westchester County, N.Y.) and
are infectious to humans.
View larger version (21K):
[in this window]
[in a new window]
|
FIG. 1.
Schematic representation of six MluI PFG
types among B. burgdorferi clinical isolates. The
approximate sizes of each fragment (in kilobases) are noted.
|
|
The plasmid contents in the same isolates were also analyzed by PFGE.
Since repeated culture passage is known to result in selective plasmid
loss (2, 18, 20), isolates in the present study were
analyzed between passages 2 and 5. Most isolates tested carried all of
the plasmids previously identified in strain B31. The most distinctive
difference among the isolates discernible by PFGE was the presence or
absence of lp38, which was confirmed by Southern blotting with an
ospD-specific probe (ospD is encoded on lp38) and
by ospD-specific PCR (data not shown). Of the isolates analyzed, 21 (44%) carried a copy of lp38. Palmer et al.
(17) recently reported the distribution of 12 linear
plasmids in 15 B. burgdorferi sensu stricto isolates by
plasmid-specific probe hybridization. These isolates were from a broad
geographic distribution; the specimen sources (human, tick, etc.) were
not given. They found that lp5, lp21, and lp56 were found in no more
than 3 of these isolates, lp17 and lp38 were present in 10 of 15 of the isolates, and the remainder were found in at least 14 of the isolates. The results of the present study are mostly consistent with and extend
those of earlier study. A difference between the two studies is the
proportion of isolates which carry lp38 (67% [10 of 15] in the study
of Palmer et al. [17] and 44% [21 of 27] in the present study [P = 0.12]). Since all the isolates in
the present study were obtained from human EM lesions, this indicates
that lp38 and its gene products are not required for infectivity.
It was of interest to ascertain whether any correlation exists between
the three typing methods applied to this group of isolates. For the
purposes of the analysis, the plasmid type (P or N) was based on the
presence or absence of lp38. Each technique scores for a specific and
seemingly unrelated genotypic character: sequence heterogeneity in a
ribosomal spacer, point polymorphisms in restriction sites distributed
across the linear chromosome, and the presence or absence of a single
linear plasmid. If these genotypic characters were independent, one
would expect that all possible combinations would be observed and would
occur at equal frequencies among the isolates tested. The data
presented in Table 1 and Fig.
2 demonstrate that these characteristics
cosegregate with each other at a highly significant rate (P < 0.001). The genotype of any individual isolate could be
designated by a combination of the three separate RSTs, PFG types, and
plasmid types. For example, an isolate which is RST1, is PFG type B,
and contains lp38 would have the designation 1BP. Only 10 of the 36 possible genotypes were observed among the 48 isolates tested; 79% (38 of 48) were one of the four predominant genotypes (1BP, 1DP, 2AN, and
3AN) (Fig. 2).
View larger version (42K):
[in this window]
[in a new window]
|
FIG. 2.
Association of RST, PFG type, and plasmid type. RST and
plasmid types are represented as one of six possible combinations and
plotted versus PFG type.
|
|
Dykhuizen et al. (4) demonstrated that there is little or
no genetic exchange between chromosomal genes in B. burgdorferi and that there is little evidence for plasmid transfer
between isolates; on this basis, they concluded that B. burgdorferi is clonal. In a separate study from that group,
linkage between ospA and ospC genotypes was
observed, even though these genes are encoded on separate plasmids
(24). The data presented here are in agreement with those
from the earlier studies and support the clonality of B. burgdorferi. Several groups have reported evidence for lateral exchange of plasmid-encoded genes in B. burgdorferi
(11, 12, 22). The mechanisms for such gene transfer are
not known, but the present data suggest that it does not occur via
exchange of entire plasmids between isolates.
We previously reported an association between rDNA spacer RFLP and
hematogenous dissemination of B. burgdorferi from skin (25). A limitation of that study was that sequence
variation in a rDNA spacer is unlikely to be a determinant of
virulence. In the present study, additional unrelated genomic loci were
examined by PFGE, and a significant correlation between the results of rDNA spacer typing and those of PFGE typing was observed. Since rDNA
spacer typing is a PCR-based method, it does not require cultivation
and can be performed rapidly with small quantities of clinical
material. The present study establishes that rDNA spacer analysis can
serve as an accurate reflection of B. burgdorferi genotype.
We thank S. Casjens, R. Marconi, S. Norris, J. Purser, and B. Stevenson for providing probes or primer sequences.
This work was supported by Public Health Service grant AR41511 from the
National Institutes of Health.
| 1.
|
Baranton, G.,
D. Postic,
I. Saint Girons,
P. Boerlin,
J.-C. Piffaretti,
M. Assous, and P. A. D. Grimont.
1992.
Delineation of Borrelia burgdorferi sensu stricto, Borrelia garinii sp. nov., and group VS461 associated with Lyme borreliosis.
Int. J. Syst. Bacteriol.
42:378-383[CrossRef][Medline].
|
| 2.
|
Barbour, A. G.
1988.
Plasmid analysis of Borrelia burgdorferi, the Lyme disease agent.
J. Clin. Microbiol.
26:475-478[Abstract/Free Full Text].
|
| 3.
|
Casjens, S.,
N. Palmer,
R. van Vugt,
W. M. Huang,
B. Stevenson,
P. Rosa,
R. Lathigra,
G. Sutton,
J. Peterson,
R. J. Dodson,
D. Haft,
E. Hickey,
M. Gwinn,
O. White, and C. M. Fraser.
2000.
A bacterial genome in flux: the twelve linear and nine circular extrachromosomal DNAs in an infectious isolate of the Lyme disease spirochete, Borrelia burgdorferi.
Mol. Microbiol.
35:490-516[CrossRef][Medline].
|
| 4.
|
Dykhuizen, D. E.,
D. S. Polin,
J. J. Dunn,
B. Wilske,
V. Preac-Mursic,
R. J. Dattwyler, and B. J. Luft.
1993.
Borrelia burgdorferi is clonal: implications for taxonomy and vaccine development.
Proc. Natl. Acad. Sci. USA
90:10163-10167[Abstract/Free Full Text].
|
| 5.
|
Ferdows, M. S.,
P. Serwer,
G. A. Griess,
S. J. Norris, and A. G. Barbour.
1996.
Conversion of a linear to a circular plasmid in the relapsing fever agent Borrelia hermsii.
J. Bacteriol.
178:793-800[Abstract/Free Full Text].
|
| 6.
|
Foretz, M.,
D. Postic, and G. Baranton.
1997.
Phylogenetic analysis of Borrelia burgdorferi sensu stricto by arbitrarily primed PCR and pulsed-field gel electrophoresis.
Int. J. Syst. Bacteriol.
47:11-18[CrossRef][Medline].
|
| 7.
|
Fraser, C. M.,
S. Casjens,
W. Huang,
G. G. Sutton,
R. Clayton,
R. Lathigra,
O. White,
K. A. Ketchum,
R. Dodson,
E. K. Hickey,
M. Gwinn,
B. Dougherty,
J.-F. Tomb,
R. D. Fleischmann,
D. Richardson,
J. Peterson,
A. R. Kerlavage,
J. Quackenbush,
S. Salzberg,
M. Hanson,
R. van Vugt,
N. Palmer,
M. D. Adams,
J. Gocayne,
J. Weidman,
T. Utterback,
L. Watthey,
L. McDonald,
P. Artiach,
C. Bowman,
S. Garland,
C. Fujii,
M. D. Cotton,
K. Horst,
K. Roberts,
B. Hatch,
H. O. Smith, and J. C. Venter.
1997.
Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi.
Nature
390:580-586[CrossRef][Medline].
|
| 8.
|
Liveris, D.,
A. Gazumyan, and I. Schwartz.
1995.
Molecular typing of Borrelia burgdorferi sensu lato by PCR-restriction fragment length polymorphism analysis.
J. Clin. Microbiol.
33:589-595[Abstract].
|
| 9.
|
Liveris, D.,
S. Varde,
R. Iyer,
S. Koenig,
S. Bittker,
D. Cooper,
D. McKenna,
J. Nowakowski,
R. B. Nadelman,
G. P. Wormser, and I. Schwartz.
1999.
Genetic diversity of Borrelia burgdorferi in Lyme disease patients determined by culture compared to direct polymerase chain reaction on clinical specimens.
J. Clin. Microbiol.
37:565-569[Abstract/Free Full Text].
|
| 10.
|
Liveris, D.,
G. P. Wormser,
J. Nowakowski,
R. Nadelman,
S. Bittker,
D. Cooper,
S. Varde,
F. H. Moy,
G. Forseter,
C. S. Pavia, and I. Schwartz.
1996.
Molecular typing of Borrelia burgdorferi from Lyme disease patients by PCR-restriction fragment length polymorphism analysis.
J. Clin. Microbiol.
34:1306-1309[Abstract].
|
| 11.
|
Livey, I.,
C. P. Gibbs,
R. Schuster, and F. Dorner.
1995.
Evidence for lateral transfer and recombination in OspC variation in Lyme disease Borrelia.
Mol. Microbiol.
18:257-269[CrossRef][Medline].
|
| 12.
|
Marconi, R. T.,
D. S. Samuels,
R. K. Landry, and C. F. Garon.
1994.
Analysis of the distribution and molecular heterogeneity of the ospD gene among the Lyme disease spirochetes: evidence for lateral gene exchange.
J. Bacteriol.
176:4572-4582[Abstract/Free Full Text].
|
| 13.
|
Mathiesen, D. A.,
J. H. Oliver, Jr.,
C. P. Kolbert,
E. D. Tullson,
B. J. Johnson,
G. L. Campbell,
P. D. Mitchell,
K. D. Reed,
S. R. Telford III,
J. F. Anderson,
R. S. Lane, and D. H. Persing.
1997.
Genetic heterogeneity of Borrelia burgdorferi in the United States.
J. Infect. Dis.
175:98-107[Medline].
|
| 14.
|
Nadelman, R. B.,
J. Nowakowski,
G. Forseter,
N. S. Goldberg,
S. Bittker,
D. Cooper,
M. Aguero-Rosenfeld, and G. P. Wormser.
1996.
The clinical spectrum of early Lyme borreliosis in patients with culture-confirmed erythema migrans.
Am. J. Med.
100:502-508[CrossRef][Medline].
|
| 15.
|
Nadelman, R. B., and G. P. Wormser.
1998.
Lyme borreliosis.
Lancet
352:557-565[CrossRef][Medline].
|
| 16.
|
Orloski, K. A.,
E. B. Hayes,
G. L. Campbell, and D. T. Dennis.
2000.
Surveillance for Lyme disease United States, 1992-1998.
Morb. Mortal. Wkly. Rep.
49(SS-3):1-11[Medline].
|
| 17.
|
Palmer, N.,
C. Fraser, and S. Casjens.
2000.
Distribution of twelve linear extrachromosomal DNAs in natural isolates of Lyme disease spirochetes.
J. Bacteriol.
182:2476-2480[Abstract/Free Full Text].
|
| 18.
|
Schwan, T. G.,
W. Burgdorfer, and C. F. Garon.
1988.
Changes in infectivity and plasmid profile of the Lyme disease spirochete, Borrelia burgdorferi, as a result of in vitro cultivation.
Infect. Immun.
56:1831-1836[Abstract/Free Full Text].
|
| 19.
|
Schwartz, I.,
G. P. Wormser,
J. J. Schwartz,
D. Cooper,
P. Weissensee,
A. Gazumyan,
E. Zimmermann,
N. S. Goldberg,
S. Bittker,
G. L. Campbell, and C. S. Pavia.
1992.
Diagnosis of early Lyme disease by polymerase chain reaction amplification and culture of skin biopsies from erythema migrans lesions.
J. Clin. Microbiol.
30:3082-3088[Abstract/Free Full Text].
|
| 20.
|
Simpson, W. J.,
C. F. Garon, and T. G. Schwan.
1990.
Analysis of supercoiled circular plasmids in infectious and non-infectious Borrelia burgdorferi.
Microb. Pathog.
8:109-118[CrossRef][Medline].
|
| 21.
|
Walker, D. H.,
A. G. Barbour,
J. H. Oliver,
R. S. Lane,
J. S. Dumler,
D. T. Dennis,
D. H. Persing,
A. F. Azad, and E. McSweegan.
1996.
Emerging bacterial zoonotic and vector-borne diseases. Ecological and epidemiological factors.
JAMA
275:463-469[Abstract].
|
| 22.
|
Wang, G.,
A. P. van Dam, and J. Dankert.
1999.
Evidence for frequent OspC gene transfer between Borrelia valaisiana sp. nov. and other Lyme disease spirochetes.
FEMS Microbiol. Lett.
177:289-296[CrossRef][Medline].
|
| 23.
|
Wang, G.,
A. P. van Dam,
I. Schwartz, and J. Dankert.
1999.
Molecular typing of Borrelia burgdorferi sensu lato: taxonomic, epidemiological, and clinical implications.
Clin. Microbiol. Rev.
12:633-653[Abstract/Free Full Text].
|
| 24.
|
Wang, I.,
D. E. Dykhuizen,
W. Qui,
J. J. Dunn,
E. M. Bosler, and B. J. Luft.
1999.
Genetic diversity of ospC in a local population of Borrelia burgdorferi sensu stricto.
Genetics
151:15-30[Abstract/Free Full Text].
|
| 25.
|
Wormser, G. P.,
D. Liveris,
J. Nowakowski,
R. B. Nadelman,
L. F. Cavaliere,
D. McKenna,
D. Holmgren, and I. Schwartz.
1999.
Association of specific subtypes of Borrelia burgdorferi with hematogenous dissemination in early Lyme disease.
J. Infect. Dis.
180:720-725[CrossRef][Medline].
|
![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
Top
Abstract
Text
